ASCO 2021: Addition of palbociclib to fulvestrant attains overall survival benefit in advanced breast cancer with update of PALOMA-3 June 15, 2021
ASCO 2021: Updated results of MONALEESA-3 show sustained overall survival benefits with ribociclib in advanced breast cancer June 15, 2021